{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T20:24:23Z","timestamp":1743452663372},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T00:00:00Z","timestamp":1326153600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Clevudine is a nucleoside analog reverse transcriptase inhibitor that exhibits potent antiviral activity against hepatitis B virus (HBV) without serious side effects. However, mitochondrial myopathy has been observed in patients with chronic HBV infection taking clevudine. Moreover, the development of diabetes was recently reported in patients receiving long-term treatment with clevudine. In this study, we investigated the effects of clevudine on mitochondrial function and insulin release in a rat clonal \u03b2-cell line, INS-1E.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The mitochondrial DNA (mtDNA) copy number and the mRNA levels were measured by using quantitative PCR. MTT analysis, ATP\/lactate measurements, and insulin assay were performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Both INS-1E cells and HepG2 cells, which originated from human hepatoma, showed dose-dependent decreases in mtDNA copy number and cytochrome c oxidase-1 (Cox-1) mRNA level following culture with clevudine (10 \u03bcM-1 mM) for 4 weeks. INS-1E cells treated with clevudine had reduced total mitochondrial activities, lower cytosolic ATP contents, enhanced lactate production, and more lipid accumulation. Insulin release in response to glucose application was markedly decreased in clevudine-treated INS-1E cells, which might be a consequence of mitochondrial dysfunction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our data suggest that high-dose treatment with clevudine induces mitochondrial defects associated with mtDNA depletion and impairs glucose-stimulated insulin secretion in insulin-releasing cells. These findings partly explain the development of diabetes in patients receiving clevudine who might have a high susceptibility to mitochondrial toxicity.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-230x-12-4","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T07:35:21Z","timestamp":1326180921000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["High-dose clevudine impairs mitochondrial function and glucose-stimulated insulin secretion in INS-1E cells"],"prefix":"10.1186","volume":"12","author":[{"given":"Yoon-Ok","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianglan","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjan","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choon-Hee","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan Mug","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon-Koo","family":"Baik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Deok","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu-Sang","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,10]]},"reference":[{"issue":"2","key":"686_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.7326\/0003-4819-150-2-200901200-00100","volume":"150","author":"MF Sorrell","year":"2009","unstructured":"Sorrell MF, Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, Kern ER, McHugh JA, Petersen GM, Rein MF, et al: National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. Ann Intern Med. 2009, 150 (2): 104-110.","journal-title":"Ann Intern Med"},{"issue":"2","key":"686_CR2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1128\/AAC.40.2.380","volume":"40","author":"S Balakrishna Pai","year":"1996","unstructured":"Balakrishna Pai S, Liu SH, Zhu YL, Chu CK, Cheng YC: Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracil. Antimicrobial agents and chemotherapy. 1996, 40 (2): 380-386.","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"10","key":"686_CR3","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1086\/429697","volume":"191","author":"PW Mallon","year":"2005","unstructured":"Mallon PW, Unemori P, Sedwell R, Morey A, Rafferty M, Williams K, Chisholm D, Samaras K, Emery S, Kelleher A, et al: In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA. J Infect Dis. 2005, 191 (10): 1686-1696. 10.1086\/429697.","journal-title":"J Infect Dis"},{"issue":"10","key":"686_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nrd1201","volume":"2","author":"W Lewis","year":"2003","unstructured":"Lewis W, Day BJ, Copeland WC: Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev Drug Discov. 2003, 2 (10): 812-822. 10.1038\/nrd1201.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"686_CR5","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/0006-2952(96)00049-4","volume":"51","author":"GQ Yao","year":"1996","unstructured":"Yao GQ, Liu SH, Chou E, Kukhanova M, Chu CK, Cheng YC: Inhibition of Epstein-Barr virus replication by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil. Biochem Pharmacol. 1996, 51 (7): 941-947. 10.1016\/0006-2952(96)00049-4.","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"686_CR6","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.1128\/JVI.02066-09","volume":"84","author":"SY Kwon","year":"2010","unstructured":"Kwon SY, Park YK, Ahn SH, Cho ES, Choe WH, Lee CH, Kim BK, Ko SY, Choi HS, Park ES, et al: Identification and characterization of clevudine-resistant mutants of hepatitis B virus isolated from chronic hepatitis B patients. J Virol. 2010, 84 (9): 4494-4503. 10.1128\/JVI.02066-09.","journal-title":"J Virol"},{"issue":"6","key":"686_CR7","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1002\/hep.22959","volume":"49","author":"JI Seok","year":"2009","unstructured":"Seok JI, Lee DK, Lee CH, Park MS, Kim SY, Kim HS, Jo HY, Kim DS: Long-term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA. Hepatology. 2009, 49 (6): 2080-2086. 10.1002\/hep.22959.","journal-title":"Hepatology"},{"issue":"9","key":"686_CR8","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1872-034X.2009.00515.x","volume":"39","author":"WY Tak","year":"2009","unstructured":"Tak WY, Park SY, Jung MK, Jeon SW, Cho CM, Kweon YO, Kim SK, Choi YH: Mitochondrial myopathy caused by clevudine therapy in chronic hepatitis B patients. Hepatol Res. 2009, 39 (9): 944-947. 10.1111\/j.1872-034X.2009.00515.x.","journal-title":"Hepatol Res"},{"issue":"2","key":"686_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2893.2010.01281.x","volume":"18","author":"JH Jang","year":"2011","unstructured":"Jang JH, Kim JW, Jeong SH, Myung HJ, Kim HS, Park YS, Lee SH, Hwang JH, Kim N, Lee DH: Clevudine for chronic hepatitis B: antiviral response, predictors of response, and development of myopathy. J Viral Hepat. 2011, 18 (2): 84-90. 10.1111\/j.1365-2893.2010.01281.x.","journal-title":"J Viral Hepat"},{"issue":"2","key":"686_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jhep.2010.03.006","volume":"53","author":"WY Tak","year":"2010","unstructured":"Tak WY, Park SY, Cho CM, Jung MK, Jeon SW, Kweon YO, Park JY, Sohn YK: Clinical, biochemical, and pathological characteristics of clevudine-associated myopathy. J Hepatol. 2010, 53 (2): 261-266. 10.1016\/j.jhep.2010.03.006.","journal-title":"J Hepatol"},{"issue":"6","key":"686_CR11","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1210\/en.2006-0057","volume":"147","author":"A Wiederkehr","year":"2006","unstructured":"Wiederkehr A, Wollheim CB: Minireview: implication of mitochondria in insulin secretion and action. Endocrinology. 2006, 147 (6): 2643-2649. 10.1210\/en.2006-0057.","journal-title":"Endocrinology"},{"issue":"5","key":"686_CR12","first-page":"569","volume":"79","author":"GW Kim","year":"2010","unstructured":"Kim GW, Lee MY, Kim SY, Kim JH, Lee JH, Chung CH: Clevudine induced diabetes mellitus in a patient with chronic hepatitis B. Korean J Med. 2010, 79 (5): 569-572.","journal-title":"Korean J Med"},{"issue":"9","key":"686_CR13","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1097\/00002030-200306130-00007","volume":"17","author":"D Nolan","year":"2003","unstructured":"Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, Metcalf C, Latham B, Mallal S: Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS. 2003, 17 (9): 1329-1338. 10.1097\/00002030-200306130-00007.","journal-title":"AIDS"},{"issue":"4","key":"686_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/jmv.10423","volume":"70","author":"T Miura","year":"2003","unstructured":"Miura T, Goto M, Hosoya N, Odawara T, Kitamura Y, Nakamura T, Iwamoto A: Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy. J Med Virol. 2003, 70 (4): 497-505. 10.1002\/jmv.10423.","journal-title":"J Med Virol"},{"issue":"2","key":"686_CR15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/135965350701200206","volume":"12","author":"MV Stankov","year":"2007","unstructured":"Stankov MV, Lucke T, Das AM, Schmidt RE, Behrens GM: Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors. Antivir Ther. 2007, 12 (2): 205-216.","journal-title":"Antivir Ther"},{"issue":"4","key":"686_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1046-2023(02)00036-1","volume":"26","author":"A Barrientos","year":"2002","unstructured":"Barrientos A: In vivo and in organello assessment of OXPHOS activities. Methods. 2002, 26 (4): 307-316. 10.1016\/S1046-2023(02)00036-1.","journal-title":"Methods"},{"issue":"1","key":"686_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0165-0270(97)00204-5","volume":"80","author":"O Miro","year":"1998","unstructured":"Miro O, Cardellach F, Barrientos A, Casademont J, Rotig A, Rustin P: Cytochrome c oxidase assay in minute amounts of human skeletal muscle using single wavelength spectrophotometers. Journal of neuroscience methods. 1998, 80 (1): 107-111. 10.1016\/S0165-0270(97)00204-5.","journal-title":"Journal of neuroscience methods"},{"issue":"48","key":"686_CR18","doi-asserted-by":"publisher","first-page":"33347","DOI":"10.1074\/jbc.M806251200","volume":"283","author":"KS Park","year":"2008","unstructured":"Park KS, Wiederkehr A, Kirkpatrick C, Mattenberger Y, Martinou JC, Marchetti P, Demaurex N, Wollheim CB: Selective actions of mitochondrial fission\/fusion genes on metabolism-secretion coupling in insulin-releasing cells. J Biol Chem. 2008, 283 (48): 33347-33356. 10.1074\/jbc.M806251200.","journal-title":"J Biol Chem"},{"issue":"1","key":"686_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0163-7258(95)00012-6","volume":"67","author":"B Fromenty","year":"1995","unstructured":"Fromenty B, Pessayre D: Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacology & therapeutics. 1995, 67 (1): 101-154. 10.1016\/0163-7258(95)00012-6.","journal-title":"Pharmacology & therapeutics"},{"issue":"4","key":"686_CR20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.tiv.2008.01.011","volume":"22","author":"A Igoudjil","year":"2008","unstructured":"Igoudjil A, Massart J, Begriche K, Descatoire V, Robin MA, Fromenty B: High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes. Toxicology in vitro: an international journal published in association with BIBRA. 2008, 22 (4): 887-898. 10.1016\/j.tiv.2008.01.011.","journal-title":"Toxicology in vitro: an international journal published in association with BIBRA"},{"issue":"3","key":"686_CR21","doi-asserted-by":"publisher","first-page":"374","DOI":"10.2337\/diabetes.47.3.374","volume":"47","author":"ED Kennedy","year":"1998","unstructured":"Kennedy ED, Maechler P, Wollheim CB: Effects of depletion of mitochondrial DNA in metabolism secretion coupling in INS-1 cells. Diabetes. 1998, 47 (3): 374-380. 10.2337\/diabetes.47.3.374.","journal-title":"Diabetes"},{"issue":"3","key":"686_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/07853890510007188","volume":"37","author":"JA Maassen","year":"2005","unstructured":"Maassen JA, Janssen GM, t Hart LM: Molecular mechanisms of mitochondrial diabetes (MIDD). Ann Med. 2005, 37 (3): 213-221. 10.1080\/07853890510007188.","journal-title":"Ann Med"},{"issue":"3","key":"686_CR23","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2337\/diabetes.53.3.624","volume":"53","author":"S Deng","year":"2004","unstructured":"Deng S, Vatamaniuk M, Huang X, Doliba N, Lian MM, Frank A, Velidedeoglu E, Desai NM, Koeberlein B, Wolf B, et al: Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes. 2004, 53 (3): 624-632. 10.2337\/diabetes.53.3.624.","journal-title":"Diabetes"},{"issue":"5-6","key":"686_CR24","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bbabio.2006.05.001","volume":"1757","author":"M Pinti","year":"2006","unstructured":"Pinti M, Salomoni P, Cossarizza A: Anti-HIV drugs and the mitochondria. Biochim Biophys Acta. 2006, 1757 (5-6): 700-707. 10.1016\/j.bbabio.2006.05.001.","journal-title":"Biochim Biophys Acta"},{"issue":"26","key":"686_CR25","doi-asserted-by":"publisher","first-page":"23616","DOI":"10.1074\/jbc.M101114200","volume":"276","author":"SE Lim","year":"2001","unstructured":"Lim SE, Copeland WC: Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. J Biol Chem. 2001, 276 (26): 23616-23623. 10.1074\/jbc.M101114200.","journal-title":"J Biol Chem"},{"issue":"4","key":"686_CR26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jhep.2009.06.011","volume":"51","author":"RD Fleischer","year":"2009","unstructured":"Fleischer RD, Lok AS: Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B. J Hepatol. 2009, 51 (4): 787-791. 10.1016\/j.jhep.2009.06.011.","journal-title":"J Hepatol"},{"issue":"6","key":"686_CR27","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/j.1478-3231.2010.02245.x","volume":"30","author":"HJ Kim","year":"2010","unstructured":"Kim HJ, Park DI, Park JH, Cho YK, Sohn CI, Jeon WK, Kim BI: Comparison between clevudine and entecavir treatment for antiviral-naive patients with chronic hepatitis B. Liver Int. 2010, 30 (6): 834-840.","journal-title":"Liver Int"},{"issue":"Pt 14","key":"686_CR28","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1242\/jcs.026062","volume":"121","author":"DA Cunha","year":"2008","unstructured":"Cunha DA, Hekerman P, Ladriere L, Bazarra-Castro A, Ortis F, Wakeham MC, Moore F, Rasschaert J, Cardozo AK, Bellomo E, et al: Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. Journal of cell science. 2008, 121 (Pt 14): 2308-2318.","journal-title":"Journal of cell science"},{"issue":"Pt 3","key":"686_CR29","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1042\/bj20021594","volume":"370","author":"R Rossignol","year":"2003","unstructured":"Rossignol R, Faustin B, Rocher C, Malgat M, Mazat JP, Letellier T: Mitochondrial threshold effects. The Biochemical journal. 2003, 370 (Pt 3): 751-762.","journal-title":"The Biochemical journal"},{"issue":"3","key":"686_CR30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1128\/AAC.44.3.496-503.2000","volume":"44","author":"XR Pan-Zhou","year":"2000","unstructured":"Pan-Zhou XR, Cui L, Zhou XJ, Sommadossi JP, Darley-Usmar VM: Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells. Antimicrobial agents and chemotherapy. 2000, 44 (3): 496-503. 10.1128\/AAC.44.3.496-503.2000.","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"2","key":"686_CR31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/135965350801300206","volume":"13","author":"C Niu","year":"2008","unstructured":"Niu C, Murakami E, Furman PA: Clevudine is efficiently phosphorylated to the active triphosphate form in primary human hepatocytes. Antivir Ther. 2008, 13 (2): 263-269.","journal-title":"Antivir Ther"},{"issue":"10","key":"686_CR32","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1086\/513872","volume":"195","author":"H Yamanaka","year":"2007","unstructured":"Yamanaka H, Gatanaga H, Kosalaraksa P, Matsuoka-Aizawa S, Takahashi T, Kimura S, Oka S: Novel mutation of human DNA polymerase gamma associated with mitochondrial toxicity induced by anti-HIV treatment. J Infect Dis. 2007, 195 (10): 1419-1425. 10.1086\/513872.","journal-title":"J Infect Dis"},{"issue":"5","key":"686_CR33","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bbabio.2008.10.007","volume":"1787","author":"SS Chan","year":"2009","unstructured":"Chan SS, Copeland WC: DNA polymerase gamma and mitochondrial disease: understanding the consequence of POLG mutations. Biochim Biophys Acta. 2009, 1787 (5): 312-319. 10.1016\/j.bbabio.2008.10.007.","journal-title":"Biochim Biophys Acta"},{"key":"686_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1749-6632.2010.05625.x","volume":"1201","author":"CH Wang","year":"2010","unstructured":"Wang CH, Wang CC, Wei YH: Mitochondrial dysfunction in insulin insensitivity: implication of mitochondrial role in type 2 diabetes. Ann N Y Acad Sci. 2010, 1201: 157-165. 10.1111\/j.1749-6632.2010.05625.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"686_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/hep.21490","volume":"45","author":"D Lebrecht","year":"2007","unstructured":"Lebrecht D, Vargas-Infante YA, Setzer B, Kirschner J, Walker UA: Uridine supplementation antagonizes zalcitabine-induced microvesicular steatohepatitis in mice. Hepatology. 2007, 45 (1): 72-79. 10.1002\/hep.21490.","journal-title":"Hepatology"},{"issue":"1","key":"686_CR36","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/art.23235","volume":"58","author":"D Lebrecht","year":"2008","unstructured":"Lebrecht D, Deveaud C, Beauvoit B, Bonnet J, Kirschner J, Walker UA: Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice. Arthritis and rheumatism. 2008, 58 (1): 318-326. 10.1002\/art.23235.","journal-title":"Arthritis and rheumatism"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-12-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T11:39:42Z","timestamp":1686656382000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-12-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["686"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-12-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,10]]},"assertion":[{"value":"20 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"4"}}